Pituitary Neoplasms: Neoplasms which arise from or metastasize to the PITUITARY GLAND. The majority of pituitary neoplasms are adenomas, which are divided into non-secreting and secreting forms. Hormone producing forms are further classified by the type of hormone they secrete. Pituitary adenomas may also be characterized by their staining properties (see ADENOMA, BASOPHIL; ADENOMA, ACIDOPHIL; and ADENOMA, CHROMOPHOBE). Pituitary tumors may compress adjacent structures, including the HYPOTHALAMUS, several CRANIAL NERVES, and the OPTIC CHIASM. Chiasmal compression may result in bitemporal HEMIANOPSIA.Hodgkin Disease: A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen.Neurosurgery: A surgical specialty concerned with the treatment of diseases and disorders of the brain, spinal cord, and peripheral and sympathetic nervous system.Diaphragm: The musculofibrous partition that separates the THORACIC CAVITY from the ABDOMINAL CAVITY. Contraction of the diaphragm increases the volume of the thoracic cavity aiding INHALATION.Adenoma: A benign epithelial tumor with a glandular organization.Growth Hormone-Secreting Pituitary Adenoma: A pituitary tumor that secretes GROWTH HORMONE. In humans, excess HUMAN GROWTH HORMONE leads to ACROMEGALY.Acromegaly: A condition caused by prolonged exposure to excessive HUMAN GROWTH HORMONE in adults. It is characterized by bony enlargement of the FACE; lower jaw (PROGNATHISM); hands; FEET; HEAD; and THORAX. The most common etiology is a GROWTH HORMONE-SECRETING PITUITARY ADENOMA. (From Joynt, Clinical Neurology, 1992, Ch36, pp79-80)Neurosurgical Procedures: Surgery performed on the nervous system or its parts.Periodicals as Topic: A publication issued at stated, more or less regular, intervals.Sphenoid Bone: An irregular unpaired bone situated at the SKULL BASE and wedged between the frontal, temporal, and occipital bones (FRONTAL BONE; TEMPORAL BONE; OCCIPITAL BONE). Sphenoid bone consists of a median body and three pairs of processes resembling a bat with spread wings. The body is hollowed out in its inferior to form two large cavities (SPHENOID SINUS).Brain Abscess: A circumscribed collection of purulent exudate in the brain, due to bacterial and other infections. The majority are caused by spread of infected material from a focus of suppuration elsewhere in the body, notably the PARANASAL SINUSES, middle ear (see EAR, MIDDLE); HEART (see also ENDOCARDITIS, BACTERIAL), and LUNG. Penetrating CRANIOCEREBRAL TRAUMA and NEUROSURGICAL PROCEDURES may also be associated with this condition. Clinical manifestations include HEADACHE; SEIZURES; focal neurologic deficits; and alterations of consciousness. (Adams et al., Principles of Neurology, 6th ed, pp712-6)Sinus Thrombosis, Intracranial: Formation or presence of a blood clot (THROMBUS) in the CRANIAL SINUSES, large endothelium-lined venous channels situated within the SKULL. Intracranial sinuses, also called cranial venous sinuses, include the superior sagittal, cavernous, lateral, petrous sinuses, and many others. Cranial sinus thrombosis can lead to severe HEADACHE; SEIZURE; and other neurological defects.Cerebrospinal Fluid Rhinorrhea: Discharge of cerebrospinal fluid through the nose. Common etiologies include trauma, neoplasms, and prior surgery, although the condition may occur spontaneously. (Otolaryngol Head Neck Surg 1997 Apr;116(4):442-9)Prolactinoma: A pituitary adenoma which secretes PROLACTIN, leading to HYPERPROLACTINEMIA. Clinical manifestations include AMENORRHEA; GALACTORRHEA; IMPOTENCE; HEADACHE; visual disturbances; and CEREBROSPINAL FLUID RHINORRHEA.Abscess: Accumulation of purulent material in tissues, organs, or circumscribed spaces, usually associated with signs of infection.Aphasia: A cognitive disorder marked by an impaired ability to comprehend or express language in its written or spoken form. This condition is caused by diseases which affect the language areas of the dominant hemisphere. Clinical features are used to classify the various subtypes of this condition. General categories include receptive, expressive, and mixed forms of aphasia.Cranial Sinuses: Large endothelium-lined venous channels situated between the two layers of DURA MATER, the endosteal and the meningeal layers. They are devoid of valves and are parts of the venous system of dura mater. Major cranial sinuses include a postero-superior group (such as superior sagittal, inferior sagittal, straight, transverse, and occipital) and an antero-inferior group (such as cavernous, petrosal, and basilar plexus).Sphenoid Sinus: One of the paired air spaces located in the body of the SPHENOID BONE behind the ETHMOID BONE in the middle of the skull. Sphenoid sinus communicates with the posterosuperior part of NASAL CAVITY on the same side.Pituitary Gland: A small, unpaired gland situated in the SELLA TURCICA. It is connected to the HYPOTHALAMUS by a short stalk which is called the INFUNDIBULUM.Pituitary Gland, Anterior: The anterior glandular lobe of the pituitary gland, also known as the adenohypophysis. It secretes the ADENOHYPOPHYSEAL HORMONES that regulate vital functions such as GROWTH; METABOLISM; and REPRODUCTION.Pituitary Gland, Intermediate: The intermediate lobe of the pituitary gland. It shows considerable size variation among the species, small in humans, and large in amphibians and lower vertebrates. This lobe produces mainly MELANOCYTE-STIMULATING HORMONES and other peptides from post-translational processing of pro-opiomelanocortin (POMC).Pro-Opiomelanocortin: A 30-kDa protein synthesized primarily in the ANTERIOR PITUITARY GLAND and the HYPOTHALAMUS. It is also found in the skin and other peripheral tissues. Depending on species and tissues, POMC is cleaved by PROHORMONE CONVERTASES yielding various active peptides including ACTH; BETA-LIPOTROPIN; ENDORPHINS; MELANOCYTE-STIMULATING HORMONES; and others (GAMMA-LPH; CORTICOTROPIN-LIKE INTERMEDIATE LOBE PEPTIDE; N-terminal peptide of POMC or NPP).Corticotropin-Like Intermediate Lobe Peptide: A peptide derived from the cleavage of ADRENOCORTICOTROPIC HORMONE, found primarily in the INTERMEDIATE LOBE OF PITUITARY but also in the ARCUATE NUCLEUS of basal HYPOTHALAMUS. Its sequence is identical to the C-terminal 22-amino acids of ACTH or ACTH 18-39.Melanotrophs: Neuroendocrine cells in the INTERMEDIATE LOBE OF PITUITARY. They produce MELANOCYTE STIMULATING HORMONES and other peptides from the post-translational processing of pro-opiomelanocortin (POMC).Pituitary Gland, Posterior: Neural tissue of the pituitary gland, also known as the neurohypophysis. It consists of the distal AXONS of neurons that produce VASOPRESSIN and OXYTOCIN in the SUPRAOPTIC NUCLEUS and the PARAVENTRICULAR NUCLEUS. These axons travel down through the MEDIAN EMINENCE, the hypothalamic infundibulum of the PITUITARY STALK, to the posterior lobe of the pituitary gland.Melanocyte-Stimulating Hormones: Peptides with the ability to stimulate pigmented cells MELANOCYTES in mammals and MELANOPHORES in lower vertebrates. By stimulating the synthesis and distribution of MELANIN in these pigmented cells, they increase coloration of skin and other tissue. MSHs, derived from pro-opiomelanocortin (POMC), are produced by MELANOTROPHS in the INTERMEDIATE LOBE OF PITUITARY; CORTICOTROPHS in the ANTERIOR LOBE OF PITUITARY, and the hypothalamic neurons in the ARCUATE NUCLEUS OF HYPOTHALAMUS.Pituitary Hormones, Anterior: Hormones secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Structurally, they include polypeptide, protein, and glycoprotein molecules.Adenoma, Chromophobe: A benign tumor of the anterior pituitary in which the cells do not stain with acidic or basic dyes.Colloids: Two-phase systems in which one is uniformly dispersed in another as particles small enough so they cannot be filtered or will not settle out. The dispersing or continuous phase or medium envelops the particles of the discontinuous phase. All three states of matter can form colloids among each other.Adenoma, Oxyphilic: A usually benign glandular tumor composed of oxyphil cells, large cells with small irregular nuclei and dense acidophilic granules due to the presence of abundant MITOCHONDRIA. Oxyphil cells, also known as oncocytes, are found in oncocytomas of the kidney, salivary glands, and endocrine glands. In the thyroid gland, oxyphil cells are known as Hurthle cells and Askanazy cells.Hoof and Claw: Highly keratinized processes that are sharp and curved, or flat with pointed margins. They are found especially at the end of the limbs in certain animals.Carcinoma, Renal Cell: A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma.Iron: A metallic element with atomic symbol Fe, atomic number 26, and atomic weight 55.85. It is an essential constituent of HEMOGLOBINS; CYTOCHROMES; and IRON-BINDING PROTEINS. It plays a role in cellular redox reactions and in the transport of OXYGEN.New JerseyKidney Neoplasms: Tumors or cancers of the KIDNEY.Hydroxides: Inorganic compounds that contain the OH- group.Acne Vulgaris: A chronic disorder of the pilosebaceous apparatus associated with an increase in sebum secretion. It is characterized by open comedones (blackheads), closed comedones (whiteheads), and pustular nodules. The cause is unknown, but heredity and age are predisposing factors.Skin Pigmentation: Coloration of the skin.Propionibacterium acnes: A bacteria isolated from normal skin, intestinal contents, wounds, blood, pus, and soft tissue abscesses. It is a common contaminant of clinical specimens, presumably from the skin of patients or attendants.Isotretinoin: A topical dermatologic agent that is used in the treatment of ACNE VULGARIS and several other skin diseases. The drug has teratogenic and other adverse effects.History, 19th Century: Time period from 1801 through 1900 of the common era.Dermatologic Agents: Drugs used to treat or prevent skin disorders or for the routine care of skin.History, 20th Century: Time period from 1901 through 2000 of the common era.Vitamins: Organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body.Dietary Supplements: Products in capsule, tablet or liquid form that provide dietary ingredients, and that are intended to be taken by mouth to increase the intake of nutrients. Dietary supplements can include macronutrients, such as proteins, carbohydrates, and fats; and/or MICRONUTRIENTS, such as VITAMINS; MINERALS; and PHYTOCHEMICALS.Vitamin A: Retinol and derivatives of retinol that play an essential role in metabolic functioning of the retina, the growth of and differentiation of epithelial tissue, the growth of bone, reproduction, and the immune response. Dietary vitamin A is derived from a variety of CAROTENOIDS found in plants. It is enriched in the liver, egg yolks, and the fat component of dairy products.Radiosurgery: A radiological stereotactic technique developed for cutting or destroying tissue by high doses of radiation in place of surgical incisions. It was originally developed for neurosurgery on structures in the brain and its use gradually spread to radiation surgery on extracranial structures as well. The usual rigid needles or probes of stereotactic surgery are replaced with beams of ionizing radiation directed toward a target so as to achieve local tissue destruction.Sarcoma: A connective tissue neoplasm formed by proliferation of mesodermal cells; it is usually highly malignant.Neoplasms, Radiation-Induced: Tumors, cancer or other neoplasms produced by exposure to ionizing or non-ionizing radiation.Empty Sella Syndrome: A condition when the SELLA TURCICA is not filled with pituitary tissue. The pituitary gland is either compressed, atrophied, or removed. There are two types: (1) primary empty sella is due a defect in the sella diaphragm leading to arachnoid herniation into the sellar space; (2) secondary empty sella is associated with the removal or treatment of PITUITARY NEOPLASMS.Radiotherapy: The use of IONIZING RADIATION to treat malignant NEOPLASMS and some benign conditions.Sella Turcica: A bony prominence situated on the upper surface of the body of the sphenoid bone. It houses the PITUITARY GLAND.
(1/47) Heparin-induced thrombocytopenia: confirmation of diagnosis with in vitro methods.

Profound thrombocytopenia developed in a patient during treatment with heparin for venous thrombosis. The platelet count increased toward normal when heparin administration was stopped, but fell abruptly when the drug was again given. Platelet aggregation occurred when heparin was added to the patient's platelet-rich plasma, or to normal platelets plus the patient's serum. This serum also effected release of 3H-serotonin from normal platelets. This pattern of aggregation was clearly different from that occasionally caused by heparin in a control population. The data is consistent with an effect of heparin on platelets, possibly mediated by on immune mechanism.  (+info)

(2/47) Visual failure from pituitary and parasellar tumours occurring with favourable outcome in pregnant women.

Very few cases have been reported of a successful outcome after relief by operation of severe visual failure from a pituitary or other parasellar tumour during the late stages of pregnancy. Two such cases are recorded here together with the obstetric features and follow-up studies of more than three years. Usually the deterioration of vi sion occurs in the latter half of the pregnancy and recovers rapidly after delivery, whether the onset of labour has occurred spontaneously or after induction. In subsequent pregnancies vision deteriorates at an earlier stage and becomes even more marked. Some cases are now occurring even in pregnancies induced by modern fertility drugs. The treatment of choice whenever vision is seriously threatened at any stage of pregnancy is a surgical attack on the pituitary, followed by suitable replacement therapy to ensure that the pregnancy continues.  (+info)

(3/47) Subclinical Cushing's disease accompanied by malignant hypertension and diabetes mellitus.

A 53-year-old woman was admitted because of hypertension and diabetes mellitus. Elevated diastolic blood pressure, hypertensive retinopathy and renal dysfunction indicated malignant hypertension. Adrenocorticotropic hormone (ACTH) and cortisol levels were high although there were no Cushingoid features. One mg dexamethasone administration decreased neither ACTH nor cortisol levels. Brain magnetic resonance imaging revealed a left pituitary tumor (7 mm x 6 mm). Upon removal, the tumor showed positive ACTH staining by immnohistochemistry, and was diagnosed as pituitary ACTH-secreting adenoma (Cushing's disease). Her blood pressure, renal function, blood glucose and hormone levels subsequently improved. Malignant hypertension and deteriorated diabetes mellitus may have been due to subclinical Cushing's disease.  (+info)

(4/47) Sarcomatoid renal cell carcinoma with foci of chromophobe carcinoma.

Both chromophobe carcinoma and sarcomatoid carcinoma of the kidney are rare. The former is characterized by a relatively good prognosis, while the latter is a highly aggressive tumor. Coexistence of the two components in one renal tumor, which has been reported only rarely, is therefore paradoxical. Both sarcomatoid and chromophobe renal carcinoma were diagnosed in a 52-year-old woman following nephrectomy and resection of metastases in the right lobe of the liver. She died of the disease two months after the first operation; only the sarcomatoid component of her tumor was seen in the liver metastasis and the recurrent carcinoma. Differences in phenotype, immunophenotype and DNA-ploidy patterns of the two components are reported. The intensive p53 staining observed only in the sarcomatoid area supports the role of the TP53 gene in the transformation of chromophobe renal carcinoma to sarcomatoid carcinoma.  (+info)

(5/47) Moyamoya disease associated with pituitary adenoma--report of two cases.

Moyamoya disease associated with prolactin (PRL)-producing pituitary adenomas occurred in two females with elevated blood PRL levels (285 and 120 ng/ml). Computed tomography revealed cystic tumors extending from the sella turcica to the suprasellar cistern. Carotid angiography demonstrated stenoses or obstructions of the bilateral internal carotid arteries at their end point and development of bilateral basal moyamoya vessels. Histological diagnosis in one case was PRL-producing chromophobe adenoma. No stigmata of neurofibromatosis or any history of irradiation was found. Compression of carotid arteries by the tumor was unlikely. These cases should therefore be classified as moyamoya disease accompanied by brain tumor, a very rare occurrence. The hypothalamic disturbance caused by moyamoya disease may have induced the hyperprolactinemia, resulting in secondary prolactinoma.  (+info)

(6/47) Hypopituitarism caused by a melanoma of the pituitary gland.

A clinical and pathological description is given of a case of panhypopituitarism caused by a melanoma of the pituitary gland. The possible origins of a melanoma in this site are discussed.  (+info)

(7/47) Stroke after pituitary irradiation.

BACKGROUND AND PURPOSE: Cranial irradiation may lead to accelerated atherosclerosis over several years. Stroke has been described after cranial irradiation administered for a number of conditions. However, pituitary irradiation has only rarely been associated with stroke. CASE DESCRIPTIONS: Two patients, 39 and 46 years of age, suffered strokes 13 and 20 years, respectively, after irradiation for pituitary tumors. Strokes were in the territories of small perforating arteries, but large vessels such as the carotid siphon and anterior cerebral arteries were also abnormal. Other risk factors for stroke were absent. CONCLUSIONS: It is suggested that pituitary irradiation increases the risk of subsequent stroke due to the known effects of ionizing radiation on vascular walls.  (+info)

(8/47) Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness.

BACKGROUND: Prognostic markers for renal cell carcinoma (RCC), such as patient symptoms, tumor stage, tumor size, and tumor grade, are useful for determining appropriate follow-up and selecting patients for adjuvant therapy. Histologic coagulative tumor necrosis, also reported to be a prognostic marker for RCC, has not previously been extensively described or investigated. Hence, the objective of the current study was to characterize tumor necrosis as a prognostic feature of RCC. METHODS: The authors of the current study identified 3009 patients treated surgically for RCC between 1970 and 2002 from the Mayo Clinic Nephrectomy Registry (Rochester, MN). Associations of tumor necrosis with clinical, laboratory, and pathologic features were examined with chi-square, Fisher exact test, and Wilcoxon rank-sum tests. Cancer-specific survival was estimated with the Kaplan-Meier method, and associations with outcome were assessed with Cox proportional hazard models. RESULTS: Tumor necrosis was present in 690 of 2445 (28%) clear cell, 196 of 421 (47%) papillary, and 28 of 143 (20%) chromophobe RCCs. The risk ratio for death from RCC in patients with necrotic compared with non-necrotic tumors was 5.27 (95% confidence interval [CI]: 4.56-6.09; P < 0.001) for clear cell, 4.20 (CI: 1.65-10.68; P < 0.001) for chromophobe, and 1.49 (CI: 0.81-2.74; P = 0.199) for papillary RCC. The survival difference for clear cell RCC persisted even after multivariate adjustment for tumor stage, size, and grade (risk ratio 1.90; P < 0.001). CONCLUSIONS: Histologic coagulative tumor necrosis is an independent predictor of outcome for clear cell and chromophobe RCC, and it should be routinely reported and used in clinical assessment.  (+info)

*  International Classification of Diseases for Oncology
M8270/0 Chromophobe adenoma (C75.1) M8270/3 Chromophobe carcinoma (C75.1) Chromophobe adenocarcinoma (M8271/0) Prolactinoma ( ... Black adenoma Pigmented adenoma M8373/0 Adrenal cortical adenoma, clear cell (C74.0) M8374/0 Adrenal cortical adenoma, ... Oxyphilic adenoma Oncocytic adenoma Oncocytoma Hurthle cell adenoma(C73.9) Hurthle cell tumor Follicular adenoma, oxyphilic ... NOS Pick tubular adenoma Sertoli cell adenoma Tubular androblastoma, NOS Testicular adenoma M8640/3 Sertoli cell carcinoma (C62 ...
*  List of MeSH codes (C04)
... adenoma, bile duct MeSH C04.557.470.035.095 --- adenoma, chromophobe MeSH C04.557.470.035.100 --- adenoma, islet cell MeSH ... adenoma, acidophil MeSH C04.557.465.625.650.075 --- adenoma, basophil MeSH C04.557.465.625.650.095 --- adenoma, chromophobe ... adenoma, acidophil MeSH C04.557.580.625.650.075 --- adenoma, basophil MeSH C04.557.580.625.650.095 --- adenoma, chromophobe ... adenoma MeSH C04.557.470.035.012 --- acth-secreting pituitary adenoma MeSH C04.557.470.035.025 --- adenoma, acidophil MeSH ...
*  Cancer syndrome
Tumors with increased risk in this disorder are colorectal cancer, gastric adenomas and duodenal adenomas. Nevoid basal cell ... renal cell carcinoma of chromophobe, hybrid oncocytic, or oncocytoma histology; sebaceous carcinoma; and sex cord tumors with ... An individual with this disease will have hundreds to thousands of benign adenomas throughout their colon, which will in most ... Other tumors increased in frequency include; osteomas, adrenal adenomas and carcinomas, thyroid tumors and desmoid tumors. The ...
*  Birt-Hogg-Dubé syndrome
Hybrid oncocytoma/chromophobe carcinoma, found in 50% of cases, is the most commonly found cancer, followed by chromophobe ... parathyroid adenomas, flecked chorioretinopathy, neurothekeoma, meningiomas, angiofibromas of the face, trichoblastomas, ... Renal tumors can manifest as multiple types of renal cell carcinoma, but certain pathological subtypes (including chromophobe, ... chromophobe renal cell carcinoma and renal oncocytoma. BHD-associated tumorigenesis differs between the kidney, where loss of ...
*  Anterior pituitary
A third type of pituitary adenoma secretes excess ACTH, which in turn, causes an excess of cortisol to be secreted and is the ... The pars distalis contains two types of cells including chromophobe cells and chromophil cells. The chromophils can be further ... This hypersecretion often results in the formation of a pituitary adenoma (tumour), which are benign apart from a tiny fraction ... Tropic hormones Pituitary adenoma Triple bolus test Posterior pituitary Hypopituitarism Hypothalamic-pituitary-somatic axis ...
*  List of OMIM disorder codes
TCF4 Pituitary adenoma, ACTH-secreting; 219090; AIP Pituitary adenoma, growth hormone-secreting; 102200; AIP Pituitary adenoma ... chromophobe, somatic; 144700; FLCN Renal cell carcinoma; 144700; DIRC2 Renal cell carcinoma; 144700; HNF1A Renal cell carcinoma ... PRKN Adenomas, multiple colorectal; 608456; MUTYH Adenomas, salivary gland pleomorphic; 181030; PLAG1 Adenomatous polyposis ... EIF2B4 Leydig cell adenoma, somatic, with precocious puberty; 176410; LHCGR Leydig cell hypoplasia with hypergonadotropic ...
Chromophobe adenoma | Definition of Chromophobe adenoma at Dictionary.com  Chromophobe adenoma | Definition of Chromophobe adenoma at Dictionary.com
Chromophobe adenoma definition at Dictionary.com, a free online dictionary with pronunciation, synonyms and translation. Look ... chromophil adenoma, chromophile, chromophilia, chromophilous, chromophobe, chromophobe adenoma, chromophobe cell, chromophobia ...
more infohttps://www.dictionary.com/browse/chromophobe-adenoma
Chromophobe Adenoma disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials  Chromophobe Adenoma disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials
MalaCards based summary : Chromophobe Adenoma, also known as adenoma, chromophobe, is related to adenoma and galactorrhea. An ... MalaCards organs/tissues related to Chromophobe Adenoma:. 41 Pituitary, T Cells, Thyroid, Ovary, Skin, Testes ... Drugs for Chromophobe Adenoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):. (show all 15) #. Name. ... Articles related to Chromophobe Adenoma:. (show top 50) (show all 95) #. Title. Authors. Year. ...
more infohttps://www.malacards.org/card/chromophobe_adenoma
Chromophobe adenoma: Definition with Chromophobe adenoma Pictures and Photos  Chromophobe adenoma: Definition with Chromophobe adenoma Pictures and Photos
Definition of Chromophobe adenoma with photos and pictures, translations, sample usage, and additional links for more ... chromophobe. chromophobe adenoma (current term). chromophobe cells of anterior lobe of hypophysis. chromophobe granules. ... Chromophobe Adenoma Images Lexicographical Neighbors of Chromophobe Adenoma. chromonychia. chromonychias. chromopectic. ... Medical Definition of Chromophobe adenoma. 1. A tumour of the adenohypophysis whose cells do not stain with either acid or ...
more infohttp://www.lexic.us/definition-of/chromophobe_adenoma
Adenoma, Chromophobe  Adenoma, Chromophobe
... - 2 Studies Found. Status. Study Terminated. Study Name: Gamma-Secretase Inhibitor RO4929097 in Treating ...
more infohttp://webhealthnetwork.com/clinicaltrials-search.php?q=Adenoma%2C+Chromophobe
Vasopressin | biochemistry | Britannica.com  Vasopressin | biochemistry | Britannica.com
present with chromophobe adenoma* In pituitary tumour. *production in mammals* In neurohormone ...
more infohttps://www.britannica.com/science/vasopressin
Human Reproduction: Glossary  Human Reproduction: Glossary
Chromophobe adenoma: Adenoma of the pituitary gland, consisting of cells that are neither acidophilic nor basophilic. ... Hypotheses for their origin include reduced pituitary dopamine concentration and/or a vascular isolation of the adenoma cells. ...
more infohttps://library.med.utah.edu/kw/human_reprod/glossary.html
Neurosecretory cell | definition of neurosecretory cell by Medical dictionary  Neurosecretory cell | definition of neurosecretory cell by Medical dictionary
... they are increased in chromophobe adenomas.. Claudius cells cuboidal cells, which along with Böttcher's cells form the floor of ... chromophobe cell. Chromophobe.. Clara cell. A cuboidal epithelial cell found in the lining of the terminal and the respiratory ... chromophobe cells faintly staining cells in the adenohypophysis; some are nongranular (either nonsecretory, immature ...
more infohttps://medical-dictionary.thefreedictionary.com/neurosecretory+cell
Cellphone | definition of cellphone by Medical dictionary  Cellphone | definition of cellphone by Medical dictionary
... they are increased in chromophobe adenomas.. Claudius cells cuboidal cells, which along with Böttcher's cells form the floor of ... chromophobe cell. Chromophobe.. Clara cell. A cuboidal epithelial cell found in the lining of the terminal and the respiratory ... chromophobe cells faintly staining cells in the adenohypophysis; some are nongranular (either nonsecretory, immature ...
more infohttp://medical-dictionary.thefreedictionary.com/cellphone
International Classification of Diseases for Oncology  International Classification of Diseases for Oncology
8270/0 Chromophobe adenoma. *About ICD-O **. *Using ICD-O-3 online ...
more infohttp://codes.iarc.fr/code/2710
CiNii 論文 - 
 		 			Supradiaphragmatic ectopic adrenocorticotropic hormone-secreting adenoma
 	...  CiNii 論文 - Supradiaphragmatic ectopic adrenocorticotropic hormone-secreting adenoma ...
Large invasive chromophobe adenoma with well-preserved pituitary gland : Report of a case. KEPES J. J. ... Selective excision of adenomas originating in or extending into the pituitary stalk with preservation of pituitary function ... Supradiaphragmatic ectopic adrenocorticotropic hormone-secreting adenoma * * Jung Shin JUNG Shin * Departments of Neurosurgery ... Supra-diaphragmatic Pituitary Adenoma Removed Through the Trans-tuberculum Sellae Approach : Case Report KINOSHITA Yasuyuki , ...
more infohttps://ci.nii.ac.jp/naid/10008542025
Radiation Oncology/CNS/Pituitary adenoma - Wikibooks, open books for an open world  Radiation Oncology/CNS/Pituitary adenoma - Wikibooks, open books for an open world
429 patients (acromegaly 72%, Cushing's disease 13%, chromophobe adenoma 8%, prolactin-secreting adenoma 4%, Nelson's syndrome ... 16 women, prolactin-secreting adenoma. Narrow beam proton therapy (1000 MeV) 40-120 Gy. Tested 2 month-2 years with IV TRH and ... ITEP, Russia; 1983 PMID 6314085 -- "[Proton therapy of pituitary adenomas][Article in Russian]" (Minakova EI, Med Radiol (Mosk ... Loma Linda; 2006 (1991-2001) PMID 16257131 -- "Fractionated proton beam irradiation of pituitary adenomas." (Ronson BB, Int J ...
more infohttps://en.wikibooks.org/wiki/Radiation_Oncology/CNS/Pituitary_adenoma
CA2287778A1 - Renal nuclear matrix proteins, polynucleotide sequences encoding them, and their use 
      - Google Patents  CA2287778A1 - Renal nuclear matrix proteins, polynucleotide sequences encoding them, and their use - Google Patents
12 Clear cell (areas of T2NoMx; II/Iv chromophobe adenoma) 13 Clear cell T2NxMx; II/IV 14 Poorly differentiated T4N2M1; IV/IV 2 ...
more infohttps://patents.google.com/patent/CA2287778A1/en
Brain abscess as the initial presentation of a macroprolactinoma: Case report | Neurocirugía (English edition)  Brain abscess as the initial presentation of a macroprolactinoma: Case report | Neurocirugía (English edition)
Fulminant meningitis associated with asymptomatic chromophobe adenoma. Am J Med Sci., 263 (1972), pp. 95-100. Medline ... This disease has been described in association with lymphocytic hypophysitis,4 pituitary abscess5 and adenomas.3 In this report ... Aggressive pituitary adenomas may facilitate the entry of pathogens into the CNS by causing bone erosion. This involvement ... It is advisable to include pituitary adenoma in the differential diagnosis of meningitis even though its onset as intracranial ...
more infohttp://www.revistaneurocirugia.com/en-brain-abscess-as-initial-presentation-articulo-S1130147314001468
00002115 | PEIR Digital Library  00002115 | PEIR Digital Library
RADIOLOGY: HEAD: Bone, calvarium: Chromophobe Adenoma: X-ray showing large sella turcica ...
more infohttp://peir.path.uab.edu/library/picture.php?/2378/tags/73-radiology/329-head/357-calvarium
Re: Hales method for colloidal iron  Re: Hale's method for colloidal iron
It's called chromophobe because it looks like the chromophobe adenoma of the anterior pituitary. Bob Richmond Samurai ... The fairly recently described chromophobe variant of renal cell carcinoma (I've seen them in study slide sets, but never one on ... probably because it is cited in the literature for differentiation of chromophobe RCC.<< (Bryan Llewellyn has already posted a ...
more infohttp://www.histosearch.com/histonet/Apr02/Re.HalesmethodforcolloidaA.html
Sarcoma of the sella after radiotherapy for pituitary adenoma | SpringerLink  Sarcoma of the sella after radiotherapy for pituitary adenoma | SpringerLink
Chang CH, Pool JL (1967) The radiotherapy of pituitary chromophobe adenomas: an evaluation of indication, technic, and result. ... Pituitary fibrosarcoma secondary to radiation therapy for the treatment of chromophobe adenoma (author's transl). No Shinkei ... Boelaert K, Gittoes NJ (2001) Radiotherapy for non-functioning pituitary adenomas. Eur J Endocrinol 144:569-575CrossRefPubMed ... Fisher BJ, Gaspar LE, Noone B (1993) Radiation therapy of pituitary adenoma: delayed sequelae. Radiology 187:843-846PubMed ...
more infohttps://link.springer.com/article/10.1007%2Fs00701-010-0694-6
Pituitary Tumors: Background, Pathophysiology, Epidemiology  Pituitary Tumors: Background, Pathophysiology, Epidemiology
These techniques have identified hormonal production in many chromophobe adenomas, enabling pathologists to identify hormones ... AIP mutation in pituitary adenomas in the 18th century and today. N Engl J Med. 2011 Jan 6. 364(1):43-50. [Medline]. ... Treatment of pituitary adenomas by fractionated stereotactic radiotherapy: a prospective study of 110 patients. Int J Radiat ... Castinetti F, Régis J, Dufour H, Brue T. Role of stereotactic radiosurgery in the management of pituitary adenomas. Nat Rev ...
more infohttps://emedicine.medscape.com/article/1157189-overview
  • The fairly recently described chromophobe variant of renal cell carcinoma (I've seen them in study slide sets, but never one on the hoof) indeed is supposed to mark very strongly with colloidal iron. (histosearch.com)
  • 5 histopathologic diagnoses submitted by mail on two cases of ependymoma included malignant choroid plexus tumor, chromophobe adenoma, angiosarcoma, medulloblastoma, and 20 "others. (thejns.org)
  • My pathologist has asked for it specifically, probably because it is cited in the literature for differentiation of chromophobe RCC. (histosearch.com)